ERBB2 and neoplasm: Although vaccination with both live or lysed HER-2+ tumor cells protected mice from tumor challenge, only the sub-tumorigenic dose of live cells induced a durable protection from subsequent challenge, revealing that an effective anti-tumor immunological memory was elicited.